SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Lal PathLabs informs about press release

08 May 2025 Evaluate
Dr. Lal PathLabs has informed that it attached copy of the Newspaper Advertisement(s) published in Financial Express and Jansatta on May 08, 2025, with respect to notice to Equity Shareholders regarding unclaimed Equity Shares (Final Dividend FY 2017-18), due for transfer to Investor Education and Protection Fund (IEPF) pursuant to Section 124(6) of the Companies Act, 2013. In this regard, individual notice(s)/ letter(s) have also been sent to the concerned shareholder(s) through post at their latest address available with the Company/ Depositories and the details of such shareholder(s) are being displayed on the website of the Company at www.lalpathlabs.com.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

1410.50 -20.55 (-1.44%)
24-Apr-2026 16:01 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×